首页> 外文期刊>Buletin Penelitian Sistem Kesehatan >Medicines Prices and Availability in Primary Health Cares, Hospitals and Retail Pharmacies in DKI Jakarta
【24h】

Medicines Prices and Availability in Primary Health Cares, Hospitals and Retail Pharmacies in DKI Jakarta

机译:雅加达DKI初级保健,医院和零售药房中的药品价格和库存情况

获取原文
       

摘要

Background: National Institute of Health Research and Development conducted medicines prices and availability from 2004 to 2012. The survey results show that more than 90% of medicines prices were still higher than International Reference Price. In addition, the availability of medicines in private sectors was better than in public sectors. There were several of essentials and generic medicines with low availability. The study aims to update the medicines prices and availability in health facilities. Methods: The study conducted in 6 area of DKI Jakarta: Central, East, West, South and North of Jakarta and Kepulauan Seribu. The study method follows the method developed by WHO and Health Action International.Samples are 22 items of essentials medicines that were collected from hospitals, retail pharmacies and primary health cares. Data collected based on structured questionnaire and observation. Results: In general the medicines prices were still higher than International Reference Price. Some of them could be more than 100 times higher. There were lessot changing in medicines prices pattern compared to the results survey in 2010 and 2004. Conclusion: There were wide variations between medicine prices from one and other health facilities, public versus private sectors. The best availability of medicines were in public hospitals (83.3%), then in private health facilities (80.6%) and then in primary health (57%). Recommendation: The government needs to make arrangements to the drug prices so that it would be more rational and affordable as well as increasing the availability of medicines at the Primary health cares.
机译:背景:美国国立卫生研究院(National Institute of Health Research and Development)从2004年至2012年进行了药品价格和供应情况的调查。调查结果显示,超过90%的药品价格仍高于国际参考价格。此外,私营部门的药品供应要好于公共部门。有几种必需品和非专利药物的利用率很低。这项研究旨在更新药品的价格和在医疗机构中的供应情况。方法:研究在雅加达DKI的6个区域进行:雅加达的中部,东部,西部,南部和北部以及Kepulauan Seribu。该研究方法遵循世界卫生组织和国际健康行动组织开发的方法。样品是从医院,零售药房和初级保健机构收集的22种基本药物。基于结构化问卷和观察收集的数据。结果:总体而言,药品价格仍高于国际参考价格。其中一些可能会高出100倍以上。与2010年和2004年的调查结果相比,药品价格模式的变化幅度较小/没有变化。结论:一种医疗机构和其他医疗机构(公共部门与私营部门)的药品价格差异很大。最好的药品供应是在公立医院(83.3%),然后在私人医疗机构(80.6%),然后是初级保健(57%)。建议:政府需要对药品价格进行安排,以使其更加合理和负担得起,并增加初级卫生保健机构的药品供应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号